Top

Published in:

Open Access 01-10-2015 | Mini-Review

Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective

Authors: Soumendranath Bhakat, Mahmoud E. S. Soliman

Published in: Journal of Natural Medicines | Issue 4/2015

Abstract

Chikungunya virus (CHIKV) is one of the re-emerging “neglected” tropical diseases whose recent outbreak affected not only Africa and South-East Asia but also several parts of America and Europe. To date, despite its serious nature, no antivirals or vaccines were developed in order to counter this resurgent infectious disease. The recent advancement in crystallography and availability of crystal structures of certain domains of CHIKV initiates the development of anti-CHIKV agents using structure-based drug design or synthetic medicinal chemistry approach. Despite the fact that almost 50 % of the new chemical entities against several biological targets were either obtained from natural products or natural product analogues, a very humble effort was directed towards identification of novel CHIKV inhibitors from natural products. In this review, besides a brief overview on CHIKV as well as the nature as a source of medicines, we highlight the current progress and future steps towards the discovery of CHIKV inhibitors from natural products. This report could pave the road towards the design of novel semi-synthetic derivatives with enhanced anti-viral activities.

Graphical Abstract

Rashad AA, Mahalingam S, Keller PA (2014) Chikungunya virus: emerging targets and new opportunities for medicinal chemistry. J Med Chem 57:1147–1166CrossRefPubMed

Belov GA (2014) Modulation of lipid synthesis and trafficking pathways by picornaviruses. Curr Opin Virol 9:19–23CrossRefPubMed

Hirneisen K, Reith JL, Wei J, Hoover DG, Hicks DT, Pivarnik LF, Kniel KE (2014) Comparison of pressure inactivation of caliciviruses and picornaviruses in a model food system. Innov Food Sci Emerg Technol 26:102–107CrossRef

Parashar D, Cherian S (2014) Antiviral perspectives for chikungunya virus. Biomed Res Int 2014:631642PubMedCentralCrossRefPubMed

Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4:206–220CrossRefPubMed

Li JW, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325:161–165CrossRefPubMed

Molinari G (2009) Natural products in drug discovery: present status and perspectives. Adv Exp Med Biol 655:13–27CrossRefPubMed

Molinari G (2009) Natural products in drug discovery: present status and perspectives. In: Guzman CA, Feuerstein GZ (eds) Pharmaceutical biotechnology. Springer, New York, pp 13–27CrossRef

Li JWH, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325:161–165CrossRefPubMed

10.

Teixeira RR, Pereira WL, da Silveira Costa, Oliveira AF, da Silva AM, de Oliveira AS, da Silva ML, da Silva CC, de Paula SO (2014) Natural products as source of potential dengue antivirals. Molecules 19:8151–8176CrossRefPubMed

11.

Lee S (2007) Artemisinin, promising lead natural product for various drug developments. Mini Rev Med Chem 7:411–422CrossRefPubMed

12.

Guantai E, Chibale K (2011) How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials? Malar J 10:S2PubMedCentralCrossRefPubMed

13.

Bhakat S, Karubiu W, Jayaprakash V, Soliman ME (2014) A perspective on targeting non-structural proteins to combat neglected tropical diseases: dengue, West Nile and chikungunya viruses. Eur J Med Chem 6:677–702CrossRef

14.

Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668–1688PubMedCentralCrossRefPubMed

15.

Nguyen PTV, Yu H, Keller PA (2014) Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus. J Mol Model 20:2216CrossRefPubMed

16.

Malet H, Coutard B, Jamal S, Dutartre H, Papageorgiou N, Neuvonen M, Ahola T, Forrester N, Gould EA, Lafitte D, Ferron F, Lescar J, Gorbalenya AE, de Lamballerie X, Canard B (2009) The crystal structures of chikungunya and Venezuelan equine encephalitis virus nsP3 Macro domains define a conserved adenosine binding pocket. J Virol 83:6534–6545PubMedCentralCrossRefPubMed

17.

Voss JE, Vaney M-C, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA (2010) Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography. Nature 468:709–712CrossRefPubMed

18.

Mann J (2002) Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer 2:143–148CrossRefPubMed

19.

Mondal S, Bandyopadhyay S, Ghosh MK, Mukhopadhyay S, Roy S, Mandal C (2012) Natural products: promising resources for cancer drug discovery. Anti Cancer Agents Med Chem 12:49–75CrossRef

20.

Wells T (2011) Natural products as starting points for future anti-malarial therapies: going back to our roots? Malar J 10:S3PubMedCentralCrossRefPubMed

21.

Singh IP, Bodiwala HS (2010) Recent advances in anti-HIV natural products. Nat Prod Rep 27:1781–1800CrossRefPubMed

22.

Bourjot M, Delang L, Van Hung N, Neyts J, Gueritte F, Leyssen P, Litaudon M (2012) Prostratin and 12-O-tetradecanoylphorbol 13-acetate are potent and selective inhibitors of chikungunya virus replication. J Nat Prod 75:2183–2187CrossRefPubMed

23.

Chowdhury IH, Koyanagi Y, Kobayashi S, Hamamoto Y, Yoshiyama H, Yoshida T, Yamamoto N (1990) The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway. Virology 176:126–132CrossRefPubMed

24.

Bourjot M, Leyssen P, Eydoux C, Guillemot J-C, Canard B, Rasoanaivo P, Gueritte F, Litaudon M (2012) Chemical constituents of Anacolosa pervilleana and their antiviral activities. Fitoterapia 83:1076–1080CrossRefPubMed

25.

Corlay N, Delang L, Girard-Valenciennes E, Neyts J, Clerc P, Smadja J, Gueritte F, Leyssen P, Litaudon M (2014) Tigliane diterpenes from Croton mauritianus as inhibitors of chikungunya virus replication. Fitoterapia 97:87–91CrossRefPubMed

26.

Allard P-M, Leyssen P, Martin M-T, Bourjot M, Dumontet V, Eydoux C, Guillemot J-C, Canard B, Poullain C, Gueritte F, Litaudon M (2012) Antiviral chlorinated daphnane diterpenoid orthoesters from the bark and wood of Trigonostemon cherrieri. Phytochemistry 84:160–168CrossRefPubMed

27.

Kothandan S, Swaminathan R (2014) Evaluation of in vitro antiviral activity of Vitex Negundo L., Hyptis suaveolens (L) poit., Decalepis hamiltonii Wight & Arn., to chikungunya virus. Asian Pac J Trop Dis 4(Supplement 1):S111–S115CrossRef

28.

Kaur P, Thiruchelvan M, Lee RCH, Chen H, Chen KC, Ng ML, Chu JJH (2013) Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother 57:155–167PubMedCentralCrossRefPubMed

29.

Lucas-Hourani M, Lupan A, Despres P, Thoret S, Pamlard O, Dubois J, Guillou C, Tangy F, Vidalain P-O, Munier-Lehmann H (2013) A phenotypic assay to identify chikungunya virus inhibitors targeting the nonstructural protein nsP2. J Biomol Screen 18:172–179CrossRefPubMed

30.

Pohjala L, Utt A, Varjak M, Lulla A, Merits A, Ahola T, Tammela P (2011) Inhibitors of alphavirus entry and replication identified with a stable chikungunya replicon cell line and virus-based assays. Plos One 6:e28923PubMedCentralCrossRefPubMed

31.

Bourjot M, Leyssen P, Neyts J, Dumontet V, Litaudon M (2014) Trigocherrierin a, a potent inhibitor of chikungunya virus replication. Molecules 19:3617–3627CrossRefPubMed

32.

Nothias-Scaglia L-F, Retailleau P, Paolini J, Pannecouque C, Neyts J, Dumontet V, Roussi F, Leyssen P, Costa J, Litaudon M (2014) Jatrophane diterpenes as inhibitors of chikungunya virus replication: structure-activity relationship and discovery of a potent lead. J Nat Prod 77:1505–1512CrossRefPubMed

33.

Williamson MP, McCormick TG, Nance CL, Shearer WT (2006) Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J Allergy Clin Immunol 118:1369–1374CrossRefPubMed

34.

Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP (2011) EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment, In: Makowski GS (eds) Advances in clinical chemistry, vol 53, pp 155–177

35.

Sachdeva AK, Kuhad A, Chopra K (2011) Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome. Brain Res Bull 86:165–172CrossRefPubMed

36.

Weber C, Sliva K, von Rhein C, Kümmerer BM, Schnierle BS The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection, Antiviral Res

37.

de Lamballerie X, Ninove L, Charrel RN (2009) Antiviral treatment of chikungunya virus infection. Infect Disord Drug Targets 9:101–104CrossRefPubMed

Title: Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective
Authors: Soumendranath Bhakat
Mahmoud E. S. Soliman
Publication date: 01-10-2015
Publisher: Springer Japan
Published in: Journal of Natural Medicines / Issue 4/2015
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-015-0910-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective

Abstract

Graphical Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Graphical Abstract

Please log in to get access to this content

Other articles of this Issue 4/2015

Ninjin’yoeito and ginseng extract prevent oxaliplatin-induced neurodegeneration in PC12 cells

New norditerpenoid alkaloids from Aconitum vilmorinianum Komarov

Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells

Antinociceptive and anti-inflammatory effects of myricetin 3-O-β-galactoside isolated from Davilla elliptica: involvement of the nitrergic system

Manadodioxans A−E: polyketide endoperoxides from the marine sponge Plakortis bergquistae

2,3,5-Trimethoxy-4-cresol, an anti-metastatic constituent from the solid-state cultured mycelium of Antrodia cinnamomea and its mechanism